Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026

Go back to Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026
AGENUS (NASDAQ: AGEN) Delayed: 8.68 +0.35 (4.20%)
Previous Close $8.33    52 Week High $7.49 
Open $8.26    52 Week Low $2.61 
Day High $8.74    P/E N/A 
Day Low $8.16    EPS $-1.10 
Volume 314,683